Blog
The Business Case for HEOR and Market Access in Earlier Stage Biopharma Companies
The rising costs of prescription drugs and healthcare delivery is impacting the way the pharmaceutical industry brings new medicines to market. Today, key healthcare stakeholders from the, payer, provider, accountable care organization (ACO), pharmacy benefit manager (PBM), and patient communities are playing an increased role in determining the market access strategies for new drugs. Concerned with a myriad of ...
